Reconstituting CJC-1295 and Ipamorelin Blend for Research Use
Reconstituting CJC-1295 and Ipamorelin Blend for Research Use
The CJC-1295 and Ipamorelin blend represents a sophisticated combination of growth hormone-releasing peptides extensively utilized in laboratory research investigating growth hormone secretion pathways. CJC-1295, a synthetic analogue of growth hormone-releasing hormone (GHRH), demonstrates enhanced stability through DAC (Drug Affinity Complex) conjugation, while Ipamorelin functions as a selective ghrelin receptor agonist. This lyophilized formulation containing 2mg of each peptide requires careful reconstitution to maintain molecular integrity for accurate research outcomes.
Materials Required
CJC-1295 + Ipamorelin blend lyophilized vial (2mg/2mg)
Bacteriostatic water for injection or sterile water for injection
1mL or 3mL sterile syringes with appropriate gauge needles (25-27G)
Alcohol swabs (70% isopropanol)
Sterile vial cap protectors
Laboratory balance capable of microgram precision
Controlled temperature environment (2-8°C)
Sterile work surface or laminar flow hood
Pre-Reconstitution Preparation
Prior to initiating the reconstitution process, establish a sterile working environment using appropriate aseptic techniques. Verify that the lyophilized vial exhibits proper vacuum seal integrity and absence of moisture condensation within the container. Allow both the peptide vial and chosen solvent to equilibrate to room temperature for approximately 15-20 minutes to prevent thermal shock during reconstitution. Examine the lyophilized powder for uniform appearance and absence of discoloration or crystalline irregularities that might indicate degradation.
Solvent Selection Considerations
Bacteriostatic water serves as the preferred reconstitution medium for extended storage applications due to its antimicrobial preservatives, while sterile water for injection provides optimal compatibility for immediate experimental use. The selection depends upon intended storage duration and experimental requirements, with bacteriostatic water permitting storage up to 28 days under refrigerated conditions.
Step-by-Step Reconstitution Protocol
Step 1: Sanitize the rubber stopper of the lyophilized vial using alcohol swabs, employing circular motions from center outward. Allow the alcohol to evaporate completely before proceeding.
Step 2: Using a sterile syringe, draw the calculated volume of bacteriostatic water or sterile water for injection based on desired final concentration. Ensure no air bubbles remain in the syringe barrel.
Step 3: Insert the needle through the rubber stopper at a slight angle to prevent coring. Direct the needle toward the glass wall of the vial rather than the lyophilized powder cake to minimize foaming and preserve peptide integrity.
Step 4: Slowly inject the solvent along the vial wall, allowing the liquid to flow down and gradually contact the lyophilized material. Maintain gentle pressure to prevent rapid injection that could damage the delicate peptide structures.
Step 5: Remove the needle and gently swirl the vial in circular motions to facilitate dissolution. Avoid vigorous shaking or vortexing, which may cause denaturation or aggregation of the peptides.
Step 6: Allow the solution to stand for 2-3 minutes to ensure complete dissolution. The resulting solution should appear clear and colorless without visible particulates or cloudiness.
Concentration Calculations and Options
The following table demonstrates common reconstitution volumes and their corresponding concentrations for the 4mg total peptide content:
1.0 mL
2.0 mg/mL
4.0 mg/mL
2.0 mL
1.0 mg/mL
4.0 mL
0.5 mg/mL
Storage Conditions
Following successful reconstitution, store the peptide solution under refrigerated conditions at 2-8°C to maintain stability and biological activity. When using bacteriostatic water, the reconstituted solution maintains viability for up to 28 days under proper storage conditions. Solutions prepared with sterile water should be utilized within 72 hours to ensure optimal research results. Protect from direct light exposure and avoid freeze-thaw cycles that could compromise peptide integrity.
Research Application Notes
Element SARMs provides this CJC-1295 and Ipamorelin blend specifically for laboratory research applications investigating growth hormone release mechanisms and related metabolic pathways. The reconstituted solution enables precise experimental dosing for cell culture studies, receptor binding assays, and comparative pharmacological research. Researchers should validate concentration accuracy through appropriate analytical methods and maintain detailed documentation of reconstitution parameters for experimental reproducibility.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML